Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation
- PMID: 11344577
- PMCID: PMC301506
- DOI: 10.1172/JCI107597
Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation
Abstract
Fletcher factor-deficient plasma is deficient in prekallikrein and therefore generates no bradykinin upon activation with kaolin. It also possesses a diminished rate of kaolin-activable coagulation and fibrinolysis and possesses a defect in kaolin-activable chemotactic activity. These abnormalities are also corrected by reconstitution with purified prekallikrein. Addition of intact activated Hageman factor corrected the coagulation, fibrinolytic, and chemotactic defects and addition of Hageman factor fragments corrected the fibrinolytic defect and partially corrected the chemotactic defect; neither of these corrected the kinin-generating defect. Although the Hageman factor-dependent pathways appear to be initiated by contact activation of Hageman factor, the kallikrein generated activates more Hageman factor; this feedback is necessary for the Hageman factor-dependent pathways to proceed at a normal rate. It is the absence of this feedback in Fletcher factor-deficient plasma that accounts for the diminished rate of activation of Hageman factor and therefore a diminished rate of activation of the coagulation and fibrinolytic pathways. The ability of prekallikrein to correct the coagulation, fibrinolytic, kinin-generating, and chemotactic defects of Fletcher factor-deficient plasma is consistent with the identity of the Fletcher factor and prekallikrein.
Similar articles
-
Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways.J Clin Invest. 1975 Dec;56(6):1650-62. doi: 10.1172/JCI108247. J Clin Invest. 1975. PMID: 1202089 Free PMC article.
-
Alteration of factor VII activity by activated Fletcher factor (a plasma kallikrein): a potential link between the intrinsic and extrinsic blood-clotting systems.J Lab Clin Med. 1975 Mar;85(3):405-15. J Lab Clin Med. 1975. PMID: 234996
-
The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen.J Clin Invest. 1977 Jun;59(6):1167-75. doi: 10.1172/JCI108741. J Clin Invest. 1977. PMID: 864009 Free PMC article.
-
The intrinsic coagulation-kinin pathway, complement cascades, plasma renin-angiotensin system, and their interrelationships.Crit Rev Immunol. 1981 Sep;3(1):75-93. Crit Rev Immunol. 1981. PMID: 7047077 Review.
-
The Hageman factor dependent pathways of coagulation, fibrinolysis, and kinin-generation.Semin Thromb Hemost. 1976 Jul;3(1):1-26. doi: 10.1055/s-0028-1087162. Semin Thromb Hemost. 1976. PMID: 139682 Review. No abstract available.
Cited by
-
Association of factor XI and high molecular weight kininogen in human plasma.J Clin Invest. 1977 Dec;60(6):1376-80. doi: 10.1172/JCI108898. J Clin Invest. 1977. PMID: 915004 Free PMC article.
-
Inactivation of kallikrein in human plasma.J Clin Invest. 1983 Jan;71(1):149-58. doi: 10.1172/jci110743. J Clin Invest. 1983. PMID: 6184384 Free PMC article.
-
The induction of macrophage spreading: role of coagulation factors and the complement system.J Exp Med. 1976 Dec 1;144(6):1531-44. doi: 10.1084/jem.144.6.1531. J Exp Med. 1976. PMID: 1003102 Free PMC article.
-
Characterization of a variant prekallikrein, prekallikrein Long Beach, from a family with mixed cross-reacting material-positive and cross-reacting material-negative prekallikrein deficiency.J Clin Invest. 1986 Jul;78(1):170-6. doi: 10.1172/JCI112547. J Clin Invest. 1986. PMID: 3487556 Free PMC article.
-
Human plasma kallikrein: roles in coagulation, fibrinolysis, inflammation pathways, and beyond.Front Physiol. 2023 Aug 30;14:1188816. doi: 10.3389/fphys.2023.1188816. eCollection 2023. Front Physiol. 2023. PMID: 37711466 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases